Biomarker can help identify GVHD in cancer patients after hematopoietic stem cell transplant

This article is about doctors being able to graft-versus-host disease (GVHD), where the newly transplanted immune system of the donor attacks the patient's skin and internal organs. In the artivcle, we read, '"We believe we've found a reliable biomarker in the patients' blood that is specific to graft-versus-host disease and therefore can help us to rapidly identify patients for whom standard treatment is likely to be insufficient [...] This marker can also tell us whether a patient is likely to respond to therapy and may lead to an entirely new risk assessment for the disease"' It is great we are able to have these kinds of ways of detecting diseases casued by doners, for it will make people aware ahead of time what is going on in their bodies after having a transplant. 

Link Here.